191 related articles for article (PubMed ID: 15555920)
1. Inhibition of N-linked glycosylation prevents inclusion formation by the dystonia-related mutant form of torsinA.
Bragg DC; Kaufman CA; Kock N; Breakefield XO
Mol Cell Neurosci; 2004 Dec; 27(4):417-26. PubMed ID: 15555920
[TBL] [Abstract][Full Text] [Related]
2. Perinuclear biogenesis of mutant torsin-A inclusions in cultured cells infected with tetracycline-regulated herpes simplex virus type 1 amplicon vectors.
Bragg DC; Camp SM; Kaufman CA; Wilbur JD; Boston H; Schuback DE; Hanson PI; Sena-Esteves M; Breakefield XO
Neuroscience; 2004; 125(3):651-61. PubMed ID: 15099679
[TBL] [Abstract][Full Text] [Related]
3. Characterization of human torsinA and its dystonia-associated mutant form.
Liu Z; Zolkiewska A; Zolkiewski M
Biochem J; 2003 Aug; 374(Pt 1):117-22. PubMed ID: 12780349
[TBL] [Abstract][Full Text] [Related]
4. Effects of genetic variations in the dystonia protein torsinA: identification of polymorphism at residue 216 as protein modifier.
Kock N; Naismith TV; Boston HE; Ozelius LJ; Corey DP; Breakefield XO; Hanson PI
Hum Mol Genet; 2006 Apr; 15(8):1355-64. PubMed ID: 16537570
[TBL] [Abstract][Full Text] [Related]
5. Molecular defects of the dystonia-causing torsinA mutation.
Pham P; Frei KP; Woo W; Truong DD
Neuroreport; 2006 Nov; 17(16):1725-8. PubMed ID: 17047461
[TBL] [Abstract][Full Text] [Related]
6. Dystonia-causing mutant torsinA inhibits cell adhesion and neurite extension through interference with cytoskeletal dynamics.
Hewett JW; Zeng J; Niland BP; Bragg DC; Breakefield XO
Neurobiol Dis; 2006 Apr; 22(1):98-111. PubMed ID: 16361107
[TBL] [Abstract][Full Text] [Related]
7. Loss of the dystonia-associated protein torsinA selectively disrupts the neuronal nuclear envelope.
Goodchild RE; Kim CE; Dauer WT
Neuron; 2005 Dec; 48(6):923-32. PubMed ID: 16364897
[TBL] [Abstract][Full Text] [Related]
8. Brainstem pathology in DYT1 primary torsion dystonia.
McNaught KS; Kapustin A; Jackson T; Jengelley TA; Jnobaptiste R; Shashidharan P; Perl DP; Pasik P; Olanow CW
Ann Neurol; 2004 Oct; 56(4):540-7. PubMed ID: 15455404
[TBL] [Abstract][Full Text] [Related]
9. Recombinant expression, purification, and comparative characterization of torsinA and its torsion dystonia-associated variant Delta E-torsinA.
Kustedjo K; Deechongkit S; Kelly JW; Cravatt BF
Biochemistry; 2003 Dec; 42(51):15333-41. PubMed ID: 14690443
[TBL] [Abstract][Full Text] [Related]
10. siRNA knock-down of mutant torsinA restores processing through secretory pathway in DYT1 dystonia cells.
Hewett JW; Nery FC; Niland B; Ge P; Tan P; Hadwiger P; Tannous BA; Sah DW; Breakefield XO
Hum Mol Genet; 2008 May; 17(10):1436-45. PubMed ID: 18258738
[TBL] [Abstract][Full Text] [Related]
11. Mutant torsinA, which causes early-onset primary torsion dystonia, is redistributed to membranous structures enriched in vesicular monoamine transporter in cultured human SH-SY5Y cells.
Misbahuddin A; Placzek MR; Taanman JW; Gschmeissner S; Schiavo G; Cooper JM; Warner TT
Mov Disord; 2005 Apr; 20(4):432-440. PubMed ID: 15593317
[TBL] [Abstract][Full Text] [Related]
12. The BiP molecular chaperone plays multiple roles during the biogenesis of torsinA, an AAA+ ATPase associated with the neurological disease early-onset torsion dystonia.
Zacchi LF; Wu HC; Bell SL; Millen L; Paton AW; Paton JC; Thomas PJ; Zolkiewski M; Brodsky JL
J Biol Chem; 2014 May; 289(18):12727-47. PubMed ID: 24627482
[TBL] [Abstract][Full Text] [Related]
13. TorsinA and early-onset torsion dystonia.
Bragg DC; Slater DJ; Breakefield XO
Adv Neurol; 2004; 94():87-93. PubMed ID: 14509659
[No Abstract] [Full Text] [Related]
14. Mutant torsinA interacts with tyrosine hydroxylase in cultured cells.
O'Farrell CA; Martin KL; Hutton M; Delatycki MB; Cookson MR; Lockhart PJ
Neuroscience; 2009 Dec; 164(3):1127-37. PubMed ID: 19761814
[TBL] [Abstract][Full Text] [Related]
15. Mutant torsinA, responsible for early-onset torsion dystonia, forms membrane inclusions in cultured neural cells.
Hewett J; Gonzalez-Agosti C; Slater D; Ziefer P; Li S; Bergeron D; Jacoby DJ; Ozelius LJ; Ramesh V; Breakefield XO
Hum Mol Genet; 2000 May; 9(9):1403-13. PubMed ID: 10814722
[TBL] [Abstract][Full Text] [Related]
16. Aberrant cellular behavior of mutant torsinA implicates nuclear envelope dysfunction in DYT1 dystonia.
Gonzalez-Alegre P; Paulson HL
J Neurosci; 2004 Mar; 24(11):2593-601. PubMed ID: 15028751
[TBL] [Abstract][Full Text] [Related]
17. TorsinB--perinuclear location and association with torsinA.
Hewett JW; Kamm C; Boston H; Beauchamp R; Naismith T; Ozelius L; Hanson PI; Breakefield XO; Ramesh V
J Neurochem; 2004 Jun; 89(5):1186-94. PubMed ID: 15147511
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the porcine TOR1A gene: The first step towards generation of a pig model for dystonia.
Henriksen C; Madsen LB; Bendixen C; Larsen K
Gene; 2009 Feb; 430(1-2):105-15. PubMed ID: 19028553
[TBL] [Abstract][Full Text] [Related]
19. Biochemical and cellular analysis of human variants of the DYT1 dystonia protein, TorsinA/TOR1A.
Hettich J; Ryan SD; de Souza ON; Saraiva Macedo Timmers LF; Tsai S; Atai NA; da Hora CC; Zhang X; Kothary R; Snapp E; Ericsson M; Grundmann K; Breakefield XO; Nery FC
Hum Mutat; 2014 Sep; 35(9):1101-13. PubMed ID: 24930953
[TBL] [Abstract][Full Text] [Related]
20. Altered responses to dopaminergic D2 receptor activation and N-type calcium currents in striatal cholinergic interneurons in a mouse model of DYT1 dystonia.
Pisani A; Martella G; Tscherter A; Bonsi P; Sharma N; Bernardi G; Standaert DG
Neurobiol Dis; 2006 Nov; 24(2):318-25. PubMed ID: 16934985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
